Skip to main content

Canadian Team Sequencing SARS Virus

NEW YORK, April 9 - Scientists from the Genome Science Center at the British Columbia Cancer Agency are sequencing the SARS virus, and expect to have a completed viral genome within as little as two weeks, Canadian newspapers have reported.

 

At least 30 genome researchers are involved in the project, which is being led by virologist Caroline Astell, according to a report in the Ottawa Citizen.

 

Early identifications using electron microscopy, PCR, and even a viral microarray have identified the SARS virus as a coronavirus, and the Lancet reported a study confirming these results today. But Astell told the Toronto Globe and Mail yesterday that "only 50 to 60 percent" was anything like known coronaviruses.

 

This sequencing project is part of the overall global push to nail down the biological etiology and mechanisms of a pathogen that has led to over 2,000 cases of Severe Acute Respiratory Syndrome since it was first reported in Southern Chinaand Hong Kongin late March. Labs in over 11 countries are contributing to this effort, according to press reports.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.